Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Solid forms of 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, as TOR kinase inhibitors

Solid forms of 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, as TOR kinase inhibitors

US Patent 9416134 · Granted Aug 16, 2016

Estimated economic value: $584,524,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Crystalline solid forms of N-(1-((2-(dimethylamino)ethyl)amino)-2-methyl-1-oxopr2021
Solid forms of 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-YL)-3,4-di2018
Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfo2017
Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfo2017
Solid forms comprising 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl2016
Processes for the preparation of (S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfo2015
Process for preparing a 2-alkynyl substituted 5-amino-pyrazolo-[4,3-e]-1,2,4-tri2013
Process for the preparation of 6,6-dimethyl-3-azabicyclo-[3.3.0]-hexane compound2012
Process for the preparation of 6,6-dimethyl-3-azabicyclo-[3.1.0]-hexane compound2010
Enantioselective process2006
Process for synthesis of D1 receptor antagonists2005